Suppression of T-cell response and prolongation of allograft survival in a rat model by tryptophan catabolites

European Journal of Pharmacology

Volumn 606, Issue 1-3, 2009, Pages 225-232

  Dai, Xiangchen ^a   Zhu, Bao Ting ^a  

^a Shimane University School of Medicine   (United States)

Author keywords

Allograft tolerance; Transplantation immunology; Tryptophan catabolite

Indexed keywords

3 HYDROXYANTHRANILIC ACID; 3 HYDROXYKYNURENINE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; QUINOLINIC ACID; TRYPTOPHAN;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

3-HYDROXYANTHRANILIC ACID; ANIMALS; BONE MARROW; CELL PROLIFERATION; DENDRITIC CELLS; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; MALE; RATS; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE; TRYPTOPHAN;

EID: 60949102815     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.12.053     Document Type: Article

References (28)

1. Bauer T.M., Jiga L.P., Chuang J.J., Randazzo M., Opelz G., and Terness P. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transpl. Int. 18 (2005) 95-100
2. Belladonna M.L., Puccetti P., Orabona C., Fallarino F., Vacca C., Volpi C., Gizzi S., Pallotta M.T., Fioretti M.C., and Grohmann U. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. Transplantation 84 1 Suppl (2007) S17-S20
3. Billingham M.E., Cary N.R., Hammond M.E., Kemnitz J., Marboe C., McCallister H.A., Snovar D.C., Winters G.L., and Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J. Heart Transplant. 9 (1990) 587-593
4. Fallarino F., Grohmann U., Vacca C., Bianchi R., Orabona C., Spreca A., Fioretti M.C., and Puccetti P. T cell apoptosis by tryptophan catabolism. Cell Death Diff. 9 (2002) 1069-1077
5. Frumento G., Rotondo R., Tonetti M., Damonte G., Benatti U., and Ferrara G.B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196 (2002) 459-468
6. Funeshima N., Fujino M., Kitazawa Y., Hara Y., Hayakawa K., Okuyama T., Kimura H., and Li X.K. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase. J. Gene Med. 7 (2005) 565-575
7. Hackstein H., and Thomson A.W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4 (2004) 24-34
8. Haudebourg T., Dugast A.S., Coulon F., Usal C., Triebel F., and Vanhove B. Depletion of LAG-3 positive cells in cardiac allograft reveals their role in rejection and tolerance. Transplantation 84 (2007) 1500-1506
9. Hayaishi O. Properties and function of indoleamine 2,3-dioxygenase. J. Biochem. 79 (1976) 13P-21P
10. Hayaishi O. Properties and function of indoleamine 2,3-dioxygenase. J. Biochem. 79 (2002) 13P-21P
11. Lee G.K., Park H.J., Macleod M., Chandler P., Munn D.H., and Mellor A.L. Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 107 (2002) 452-460
12. Mackay G.M., Forrest C.M., Stoy N., Christofides J., Egerton M., Stone T.W., and Darlington L.G. Tryptophan metabolism and oxidative stress in patients with chronic brain injury. Eur. J. Neurol. 13 (2006) 30-42
13. Mellor A.L., and Munn D.H. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?. Immunol. Today 20 (1999) 469-473
14. Mellor A.L., Sivakumar J., Chandler P., Smith K., Molina H., Mao D., and Munn D.H. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2 (2001) 64-68
15. Mellor A.L., and Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4 (2004) 762-774
16. Moser M. Dendritic cells in immunity and tolerance - do they display opposite functions?. Immunity 19 (2003) 5-8
17. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., Brown C., and Mellor A.L. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 (1998) 1191-1193
18. Munn D.H., Shafizadeh E., Attwood J.T., Bondarev I., Pashine A., and Mellor A.L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189 (1999) 1363-1372
19. Munn D.H., Sharma M.D., Lee J.R., Jhaver K.G., Johnson T.S., Keskin D.B., Marshall B., Chandler P., Antonia S.J., Burgess R., Slingluff Jr. C.L., and Mellor A.L. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297 (2002) 1867-1870
20. Ono K., and Lindsey E.S. Improved technique of heart transplantation in rats. J. Thorac. Cardiovasc. Surg. 57 (1969) 225-229
21. Radu C.A., Bosch N., Bauer T.M., Kleist C., Jiga L., Terness P., Opelz G., Gebhard M.M., Germann G., and Baumeister S. Immunosuppressive effect of tryptophan metabolites in composite tissue allotransplantation. Plast. Reconstr. Surg. 119 (2007) 2023-2028
22. Suzuki S., Tone S., Takikawa O., Kubo T., Kohno I., and Minatogawa Y. Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti. Biochem. J. 355 (2001) 425-429
23. Takikawa O., Yoshida R., Kido R., and Hayaishi O. Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J. Biol. Chem. 261 (1986) 3648-3653
24. Taylor M.W., and Feng G. Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5 (1991) 2516-2522
25. Terness P., Bauer T.M., Röse L., Duffer C., Watzlik A., Simon H., and Opelz G. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196 (2002) 447-457
26. Yoshida R., Nukiwa T., Watanabe Y., Fujiwara M., Hirata F., and Hayashi O. Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymis of mice. Arch. Biochem. Biophys. 203 (1980) 343-351
27. + T cells induced by TCR triggering or homeostatic cytokines. Eur. J. Immunol. 36 (2006) 296-304
28. Werner E.R., Bitterlich G., Fuchs D., Hausen A., Reibnegger G., Szabo G., Dierich M.P., and Wachter H. Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sci. 41 (1987) 273-280